Pfizer and Moderna DECLINED joining Johnson & Johnson study of vaccine blood clot risks
Johnson & Johnson privately reached out to rival COVID-19 vaccine makers to join in an effort to study the risks of blood clots. According to The Wall Street Journal, citing three people familiar with the matter, J&J wanted to form an informal alliance with other companies to communicate with one one voice about the benefits … Read more